BiotechTube
Home/IGC Pharma/Terry Lierman
TL

Terry Lierman

Director

IGC Pharma

Therapeutic Areas

Alzheimer's DiseaseCentral Nervous System Disorders

IGC Pharma Pipeline

DrugIndicationPhase
IGC-AD1Agitation in Alzheimer's DementiaPhase 2
TGR-63Early-Moderate Stage Alzheimer's (Aβ Plaques)Preclinical
IGC-1CAlzheimer's (Tau pathology)Preclinical
IGC-M3Alzheimer's (Aβ Plaques aggregation)Preclinical
IGC-LMPAlzheimer's Agitation Symptoms (Neuroinflammation)Preclinical

Leadership Team at IGC Pharma

RM
Ram Mukunda
CEO & Director
CG
Claudia Grimaldi
VP, CCO, PFO, & Director
RP
Richard Prins
Chairman of the Board
JM
Jim Moran
Director
PP
Prof. Pablo Arbeláez
Advisor (AI)
PC
Prof. Chuanhai Cao, Ph.D.
Advisor (Pharmaceutical Sciences)
PE
Prof. Elliot L. Hong
Advisor (Psychiatry)
PJ
Prof. Joseph Fortunak, Ph.D.
Advisor (Chemistry & Pharmaceutical Sciences)
PT
Prof. T. Govindaraju, Ph.D, FRSC
Advisor (Bioorganic Chemistry)
View full IGC Pharma profile